Clinical Study Results
What adverse reactions did the participants have?
The most common adverse reaction during the study was nausea.
The table below shows the adverse reactions that happened in at least 2 participants during the
study. There were other adverse reactions that happened during the study, but those happened
in fewer participants.
Most common adverse reactions during the study
MEDI0382, metformin, Placebo, metformin,
and dapagliflozin and dapagliflozin
(out of 25 participants) (out of 24 participants)
Nausea 20.0% (5) 4.2% (1)
Vomiting 16.0% (4) 0.0% (0)
Constipation 12.0% (3) 0.0% (0)
Headache 8.0% (2) 4.2% (1)
Fast heart beat 4.0% (1) 8.3% (2)
Dizziness 8.0% (2) 0.0% (0)
Pain in upper gut area 8.0% (2) 0.0% (0)
Decreased appetite 4.0% (1) 4.2% (1)
Diarrhea 4.0% (1) 4.2% (1)
How has this study helped patients and researchers?
This study helped researchers learn how MEDI0382 affects blood sugar levels in people who
have type 2 diabetes and are overweight or have obesity.
Researchers look at the results of many studies to decide which treatments work best and are
safest. This summary shows only the main results from this one study. Other studies may provide
new information or different results.
Further clinical studies with MEDI0382 are planned.
7